Basic Information
ID: ALA5054067
Type: Binding
Description: Modulation of capsid assembly in HBV infected in human HepG2.2.15 cells assessed as inhibition of viral DNA replication preincubated for 3 days followed by replacement with fresh medium containing compound and measured after 3 days by QuantiGene assay
Organism: Hepatitis B virus
Cell type: HepG2.2.15
Activity Charts
Bioactivity
Activity Types for Assay ALA5054067
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 352.83 | 4.32 | 4.32 |
| 403.87 | 3.21 | 3.21 |
| 393.83 | 1.65 | 1.65 |
| 423.83 | 1.64 | 1.64 |
| 437.86 | 2.03 | 2.03 |
| 377.83 | 2.68 | 2.68 |
| 437.86 | 2.03 | 2.03 |
| 391.86 | 3.07 | 3.07 |
| 519.48 | 1.98 | 1.98 |
| 417.44 | 1.69 | 1.69 |
| 433.90 | 2.84 | 2.84 |
| 398.40 | 1.89 | 1.89 |
| 428.42 | 1.25 | 1.25 |
| 377.83 | 2.68 | 2.68 |
| 389.84 | 2.82 | 2.82 |
| 377.83 | 2.68 | 2.68 |
| 391.86 | 3.07 | 3.07 |
| 348.79 | 2.83 | 2.83 |
| 361.83 | 2.75 | 2.75 |
| 346.82 | 3.64 | 3.64 |
| 405.84 | 2.06 | 2.06 |
| 423.83 | 1.64 | 1.64 |
| 419.87 | 2.45 | 2.45 |
| 349.78 | 1.94 | 1.94 |
| 377.83 | 2.68 | 2.68 |
| 430.42 | 2.23 | 2.23 |
| 423.83 | 1.64 | 1.64 |
| 471.41 | 2.40 | 2.40 |
| 464.93 | 2.60 | 2.60 |
| 437.86 | 2.03 | 2.03 |
| 391.86 | 3.07 | 3.07 |
| 418.89 | 1.97 | 1.97 |
| 363.81 | 2.29 | 2.29 |
| 437.86 | 2.03 | 2.03 |
| 375.82 | 2.43 | 2.43 |
| 492.46 | 2.54 | 2.54 |